Finance

Beta
Lists
4884:TYO
Kringle Pharma Inc
¥303.00
-1.62%
(-5.00) 1D
Jun 12, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4884...
Open
¥312
High
¥317
Low
¥302
Mkt. cap
2.54B
Avg. vol.
263.67K
Volume
164.40K
52-wk high
¥1,125
52-wk low
¥300
EPS
-¥130
No. of employees
17
Open
¥312
High
¥317
Low
¥302
Mkt. cap
2.54B
Avg. vol.
263.67K
Volume
164.40K
52-wk high
¥1,125
52-wk low
¥300
EPS
-¥130
No. of employees
17
News stories
From sources across the web
About Kringle Pharma Inc
CEOKiichi Adachi
Employees17
FoundedDec 21, 2001
Headquarters-
SectorBiotechnology
Websitekringle-pharma.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
17.96M
18.11M
18.57M
17.43M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
681.00M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
244.55M
-492.41M
218.48M
333.52M
Operating expense
244.55M
188.59M
218.48M
333.52M
Total operating expenses
244.55M
188.59M
218.48M
333.52M
Operating income
-226.58M
-170.48M
-199.91M
-316.09M
Other non operating income
-112.00K
-6.00M
38.00K
962.00K
EBT including unusual items
-226.62M
-176.64M
-201.48M
-313.52M
EBT excluding unusual items
-226.62M
-176.64M
-200.05M
-313.95M
Income tax expense
372.00K
-121.00K
372.00K
628.00K
Effective tax rate
-0.16%
0.07%
-0.18%
-0.20%
Other operating expenses
-
-
-
-
Net income
-226.99M
-176.52M
-201.85M
-314.15M
Net profit margin
-1,263.52%
-974.87%
-1,086.97%
-1,802.35%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
1.00M
Interest expense
-
-141.00K
-
-
Net interest expenses
-
-141.00K
-
1.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer